Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Original Article

Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Li LY, Kim SW, Nam EJ, et al

Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer

International Journal of Gynecologic Cancer 2019;29:334-340.